Liao Carrie
SEC CIK 1899817 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | VP, Ctrl, Acct Principal | 144.9K | — | $46.8K | 7 | 2022-02-10 | 2025-03-25 |
Most active insiders at DFTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barrow Robert | CEO, Dir | — | $3.08M |
| 2 | Sullivan Mark | CLO | — | $1.04M |
| 3 | Karlin Daniel | Chief Medical Off | — | $748.9K |
| 4 | Roberts Brandi | CFO | — | $135.7K |
| 5 | Wiley Matthew T. | Chief Commercial Off | — | $129.1K |
| 6 | Adsett Roger | Dir | — | — |
| 7 | CRYSTAL ROGER | Dir | — | — |
| 8 | Bruhn Suzanne Louise | Dir | — | — |
| 9 | Krebs Andreas | Dir | — | — |
| 10 | Vallone Carol A | Dir | — | — |
Liao Carrie made no open-market trades at DFTX in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-03-26 | 2025-03-25 | DFTX | Definium Therapeutics, Inc. | Liao Carrie | CAO | S - Sale | $6.74 | -2,347 | 144.9K | -2% | -$15.8K |
| 2025-03-13 | 2025-03-12 | DFTX | Definium Therapeutics, Inc. | Liao Carrie | CAO | A - Grant | $0.00 | +50.0K | 142.3K | +54% | $0 | |
| 2024-12-27 | 2024-12-26 | DFTX | Definium Therapeutics, Inc. | Liao Carrie | CAO | S - Sale | $7.43 | -2,273 | 97.3K | -2% | -$16.9K | |
| T | 2024-09-25 | 2024-09-25 | DFTX | Definium Therapeutics, Inc. | Liao Carrie | CAO | S - Sale | $5.98 | -2,352 | 99.5K | -2% | -$14.1K |
| A | 2023-04-24 | 2023-03-14 | DFTX | Definium Therapeutics, Inc. | Liao Carrie | CAO | A - Grant | $0.00 | +75.0K | 101.9K | +279% | $0 |
| 2023-03-17 | 2023-03-14 | DFTX | Definium Therapeutics, Inc. | Liao Carrie | VP, Ctrl, Acct Principal | A - Grant | $0.00 | +75.0K | 478.4K | +19% | $0 | |
| D | 2022-03-14 | 2022-02-10 | DFTX | Definium Therapeutics, Inc. | Liao Carrie | VP, Ctrl, Acct Principal | A - Grant | $0.00 | +403.4K | 403.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations